Updated Jul 16, 2026
Adams Helen C. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Helen C. Adams (as listed in SEC filings as Adams, Helen C.) is identified as a director of Immix Biopharma, Inc. in filings dated May 29, 2026. Public disclosures accompanying the filing do not provide a detailed biographical background. Based on the available SEC context, she serves on the board of Immix Biopharma. No additional confirmed roles or achievements are publicly disclosed in the provided context.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | IMMX | Immix Biopharma, Inc. | A — Grant or award | 6.2K | $0.00 |
Helen C. Adams (as listed in SEC filings as Adams, Helen C.) is identified as a director of Immix Biopharma, Inc. in filings dated May 29, 2026. Public disclosures accompanying the filing do not provide a detailed biographical background. Based on the available SEC context, she serves on the board of Immix Biopharma. No additional confirmed roles or achievements are publicly di…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Adams Helen C. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.